Oxford Biodynamics PLC (LON:OBD) insider Peter Pack purchased 15,000 shares of the business’s stock in a transaction dated Monday, June 29th. The stock was bought at an average price of GBX 62 ($0.76) per share, with a total value of £9,300 ($11,444.75).
Shares of LON:OBD opened at GBX 59.25 ($0.73) on Wednesday. The firm has a market capitalization of $54.84 million and a price-to-earnings ratio of -15.59. The company has a debt-to-equity ratio of 3.86, a current ratio of 11.74 and a quick ratio of 11.55. The business’s 50 day simple moving average is GBX 71.35 and its 200-day simple moving average is GBX 82.95. Oxford Biodynamics PLC has a 12 month low of GBX 47 ($0.58) and a 12 month high of GBX 149.55 ($1.84).
Oxford Biodynamics (LON:OBD) last issued its quarterly earnings data on Tuesday, June 16th. The biotechnology company reported GBX (2.20) (($0.03)) earnings per share (EPS) for the quarter.
About Oxford Biodynamics
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures.
Featured Article: What is a good dividend yield?
Receive News & Ratings for Oxford Biodynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biodynamics and related companies with MarketBeat.com's FREE daily email newsletter.